Encapsulated sumatriptan is not bioequivalent to commercial sumatriptan [2] (multiple letters)

Headache

Volumn 43, Issue 8, 2003, Pages 923-928

  Salonen, Reijo ^a   Kori, Shashidhar ^a   Scott, Andrew ^a   Richardson, Mary S ^a   Mathew, Ninan T ^b   Sikes, Carolyn ^c   Muirhead, Nancy ^c  

^a GLAXOSMITHKLINE   (United States)

^b Houston Headache Clinic   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ELETRIPTAN; SUMATRIPTAN;

AREA UNDER THE CURVE; BIOEQUIVALENCE; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG EFFICACY; EVALUATION; HUMAN; LETTER; MIGRAINE; PRIORITY JOURNAL; TABLET;

CAPSULES; HUMANS; INDOLES; PYRROLIDINES; RESEARCH DESIGN; SEROTONIN AGONISTS; SUMATRIPTAN; THERAPEUTIC EQUIVALENCY; TRYPTAMINES;

EID: 0042237014     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)